(Reuters) - Gilead Sciences Inc's drug, remdesivir, showed antiviral activity against Omicron, Delta and other variants of the coronavirus in laboratory studies, the company said on Friday.The study ...
Source Link(Reuters) - Gilead Sciences Inc's drug, remdesivir, showed antiviral activity against Omicron, Delta and other variants of the coronavirus in laboratory studies, the company said on Friday.The study ...
Source Link
Comments